account_balance
Investment manager · 13F filer · SEC CIK 1917529
Atlas Venture Life Science Advisors, LLC
Reported value$881Mas of Jun 30, 2026
Positions7 1 new, 0 sold out
Top 10 weight100%KYMR alone is 37%
FiledAug 1344 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
KYMR
Kymera Therapeutics, Inc.
37.1%Trimmed
DYN
Dyne Therapeutics, Inc.
17.1%Trimmed
SION
Sionna Therapeutics, Inc.
15.0%
KLRA
Kailera Therapeutics, Inc.
12.9%New
IRON
Disc Medicine, Inc.
12.6%
QTTB
Q32 Bio, Inc.
3.9%Added
KRRO
Korro Bio, Inc.
1.4%Trimmed
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed